4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000950170-25-089721
Options or other derivatives
- Chief Commercial Officer acquired 185,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cline Darren S · Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-23 | Grant or award : show line 1 in the form Share Option (Right to Buy) | +185,800 | 185,800 | D |
Loading xslF345X05/ownership.xml…